A Smart + Strong Site
Subscribe to:
E-newsletters
POZ magazine
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » Top Stories

Most Popular Stories
Marijuana and its CD4 Receptors: A New HIV Treatment Strategy?
Pathway to a Cure: Cancer Drug Helps Purge HIV From Resting Cells
Life Expectancy With HIV Increases Dramatically
Undetectable Viral Load? Not Necessarily in Semen
Engineering CD8 Cells to Kill HIV in Tissues
Pathway to a Cure: Positive Results Continue for Sangamo's CCR5 Gene Therapy
Revised U.S. Guidelines: HIV Treatment is Recommended for All People Living With HIV
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
Aging & HIV
The HIV Life Cycle
Shingles
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to editors@aidsmeds.com.

Click here for more news


emailprint

April 15, 2009

Possible Interaction Between Isentress and Intelence?

Intelence (etravirine) may lower blood levels of Isentress (raltegravir) in some people, according to a series of case reports published in the April 27 issue of AIDS.

Isentress and Intelence, an integrase inhibitor and a non-nucleoside reverse transcriptase inhibitor, have become popular medication options for people who are heavily treatment experienced. Thus far, small studies in HIV-negative volunteers have not demonstrated that one lowers or raises blood levels of the other, but there are not substantial amounts of data involving drug combinations of both antiretrovirals in treatment-experienced HIV-positive patients.

Contrary to the studies in HIV-negative volunteers, Amélie Ménard, MD, from the Sainte Marguerite University Hospital, in Marseille, France and her colleagues report four cases of HIV-positive heavily treatment-experienced patients having significant drug interactions. In three of the cases, the patients started Isentress and Intelence at the same time. In the remaining case, the patient started taking Intelence after having been on Isentress for a while.

In all four cases, blood levels of Isentress were reduced significantly, while blood levels of Intelence stayed in the normal range. Ménard and her colleagues comment that HIV levels in the four patients did not drop as much as would have been expected after starting new regimens involving these drugs, and they believe that the reduced Isentress blood levels are the likely culprits.

The authors conclude that standard drug interaction studies involving HIV-negative volunteers may not always accurately predict what will happen in people with HIV, especially treatment-experienced patients. They recommend that providers explore therapeutic drug monitoring options to measure Isentress blood levels in patients who combine Isentress and Intelence, and that further study of these two drugs is warranted.

Search: Isentress, raltegravir, Intelence, emtricitabine, drug interactions, blood levels, Amélie Ménard


Scroll down to comment on this story.

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team review all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

comments 1 - 1 (of 1 total)    

HIVMarine, , 2009-04-15 23:22:41
Ive been on both Intellence and Insentress for about a year at first there were no instructions as to whether the entire daily doses could taken together or separate but i found after meal twice a day does the trick, and for those skeptical because undetectable took too long remember that us individuals all had the most toughest viremia to reach in the deepest part of the body takes time

comments 1 - 1 (of 1 total)    


[Go to top]

Quick Links
AIDSmeds en Español
About HIV and AIDS
Lab Tests
Clinical Trials
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Disclosure
Lipodystrophy
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Blogs
Conference Coverage
Health Services Directory
POZ Magazine


    chrisf
    san jose
    California


    RyGuy00
    Deerfield Beach
    Florida


    tempeststar
    Midtown NYC
    New York


    John_Philly_2012
    Philadelphia
    Pennsylvania
Click here to join POZ Personals!
Conference Coverage

19th Conference on Retroviruses and Opportunistic Infections (CROI 2012)
Seattle, Washington
March 5 - 8, 2012


6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011)
Rome, Italy
July 17 - 20, 2011


18th Conference on Retroviruses and Opportunistic Infections (CROI 2011)
Boston, MA
February 27 - March 2, 2011


more conference coverage

[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2012 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.